What NewChem Technologies does

NewChem Technologies Ltd. was a United Kingdom–based contract research and manufacturing services (CRAMS) provider specializing in commercial applications of organic chemistry, founded in 2002 and headquartered in Durham. The firm operated with a small specialist team (11–50 employees) focused on complex process chemistry, serving pharmaceutical and chemical sector clients. Its narrow functional focus on organic chemistry commercial applications positioned it as a niche technical service provider rather than a broad-line CDMO.

In October 2023, Sterling Pharma Solutions acquired NewChem Technologies Ltd. as part of an industry-wide consolidation trend in the CRAMS sector, explicitly to strengthen Sterling's capabilities in complex process chemistry. The acquisition reclassified the firm from an independent specialist to a subsidiary within a larger CDMO platform. Post-acquisition, NewChem operates under Sterling Pharma Solutions' corporate umbrella, and its standalone website now displays a verification/loading page, indicating limited active public presence as an independent entity.

The firm's revenue model, pricing, customer roster, specific product or service offerings, and management team are not disclosed in available source material. No patents, certifications, regulatory actions, or product launches are on record. The acquisition represents the only documented strategic event, and there is no public evidence of pre-acquisition funding history, prior M&A, or independent expansion activity.

Name

NewChem Technologies

Legal name

NewChem Technologies Ltd.

Website

https://newchemtechnologies.com

Company type

Private

Founded year

2002

Operating status

Acquired

Headcount range

11–50 employees

Short description

NewChem Technologies Ltd. was a UK-based contract research and manufacturing services firm specializing in organic chemistry commercial applications for pharmaceutical and chemical sector clients; acquired by Sterling Pharma Solutions in October 2023.

Ownership category

akta.pro rank

Product category

Pharmaceutical CRAMS Services

NAICS

Scientific Research and Development Services (5417), Pharmaceutical Preparation Manufacturing (325412)

SIC

Services-Commercial Physical & Biological Research (8731), Industrial Organic Chemicals (2860)

akta.pro primary industry

Small-Molecule API Commercial Manufacturing (HLAGAHAB)

akta.pro secondary industry

Chiral / Asymmetric Synthesis & Complex Chemistry Services (HLAGAHAE)

Keywords

• Contract research services
• Process chemistry
• Pharmaceutical manufacturing
• Organic chemistry synthesis
• CRAMS services

Headquarters

HQ city

Durham

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure

Core offering

NewChem Technologies is a contract research and manufacturing services (CRAMS) provider specializing in commercial applications for organic chemistry and complex process chemistry. The company delivers specialized chemistry services to pharmaceutical sector clients. In October 2023, NewChem Technologies Ltd. was acquired by Sterling Pharma Solutions, becoming a subsidiary within Sterling's contract development and manufacturing organization.

Product overview

No specific product or service information is available from the provided sources. The company appears to operate in the Contract Research and Manufacturing Services (CRAMS) sector based on market report context, but no named products, modules, or service offerings are detailed in the source material. NewChem Technologies Ltd. was acquired by Sterling Pharma Solutions in October 2023.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights1 record

Direct peers

• Almac Group: Almac is a UK/Ireland-based contract development and manufacturing organization offering API development, custom synthesis, and complex chemistry services. Highly comparable geography, scale, and service mix to NewChem.
• Sterling Pharma Solutions: Sterling Pharma Solutions is a UK-based CDMO that acquired NewChem in October 2023. It offers contract API development and manufacturing services across small molecules, making it the closest comparable given overlapping organic chemistry and API capabilities, and now operates NewChem as part of its portfolio.
• Carbogen Amcis: Carbogen Amcis specializes in process development, scale-up, and commercial manufacturing of complex APIs, including chiral and hazardous chemistry. Directly comparable to NewChem's specialized complex process chemistry offering.
• Hovione: Hovione is a CDMO specializing in complex small-molecule API development and manufacturing, including chiral chemistry and process development. Directly comparable to NewChem's complex process chemistry positioning for pharma clients.

Broad incumbents

• Recipharm: Recipharm is a European-headquartered CDMO providing contract development and manufacturing of APIs and finished dosage forms. Comparable service portfolio to NewChem's complex chemistry/API scope, though operating at significantly larger scale.
• Cambrex: Cambrex is an established global CDMO offering small-molecule API development and manufacturing across multiple sites. Overlaps with NewChem on organic chemistry and API services but at meaningfully larger scale and broader service breadth.
• Siegfried Holding: Siegfried is a Swiss CDMO offering API and finished dose manufacturing services. Comparable organic chemistry and small-molecule API manufacturing capabilities, though with a much broader global footprint.
• Johnson Matthey (Health division): Johnson Matthey's Health division (now divested/transitioning) offered complex API development and contract manufacturing including chiral and precious metal catalysis. Comparable complex-chemistry and precious-metal organometallic capabilities to NewChem's organic chemistry specialization.
• Eurofins CDMO: Eurofins provides contract research and manufacturing services across pharma, including custom synthesis and process chemistry. Comparable service scope to NewChem, though embedded within a much larger testing/services conglomerate.

Emerging players

• Aurigene Pharmaceutical Services: Aurigene is a CRAMS provider offering custom synthesis, process chemistry, and API development for small molecules. Comparable niche complex-chemistry services to NewChem, though based in India with a different cost structure.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NewChem Technologies